Update on Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Company"/"Amalgamated Company") and their respective Shareholders and Creditors.

pdf

Orchid Pharma Ltd.

07 Mar 2025, 01:04PM

710.50

-0.32%

Company Update

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Review of Credit Rating of Orchid Pharma Limited

pdf

Orchid Pharma Ltd.

28 Feb 2025

710.50

-0.32%

Company Update

Orchid Pharma Ltd - 524372 - Disclosure Regarding The Order Passed By Goods And Service Tax …

BSE India

Disclosure regarding the Order passed by Goods & Service Tax Department

pdf

Orchid Pharma Ltd.

19 Feb 2025

710.50

-0.32%

Company Update

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Orchid Pharma''s Alathur API facility successfully completes USFDA Inspection, maintaining its position as India''s only USFDA approved facility for Sterile Cephalosporins.

pdf

Orchid Pharma Ltd.

15 Feb 2025

710.50

-0.32%

Earnings Call

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Analyst/ Investor earning call held with public at large on February 12, 2025 for Financial Results of Quarter III of FY 2024-25 ended on December 31, 2024- Orchid Pharma Limited

pdf

Orchid Pharma Ltd.

12 Feb 2025

710.50

-0.32%

Earnings Call

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio Recording of the Analysts/Investors Earnings Call for Unaudited Financial results of Quarter III of F.Y. 2024-25 ended on December 31, 2024 - Orchid Pharma Limited

pdf

Is Orchid Pharma Ltd. worth buying?

209 Votes:

Buy 73.68%

Sell 17.22%

Hold 9.09%